Biotron Limited: Difference between revisions
>Nick Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. == References and notes == Ca..." |
(No difference)
|
Latest revision as of 07:03, 23 August 2022
Summary[1] edit edit source
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
References and notes edit edit source
- ↑ Source: Yahoo Finance.